期刊文献+

查尔酮类衍生物G01对H_2O_2诱导小鼠皮层神经元氧化损伤保护作用研究 被引量:5

Protective Effects of a Chalcone Derivative G01 on H_2O_2-induced Oxidative Damage in Cortical Neurons of Mice
下载PDF
导出
摘要 本文研究查尔酮类衍生物G01(3'-甲酰基-4',6'-二羟基-2'-甲氧基-5'-甲基-3,4-二羟基查尔酮)对H_2O_2诱导小鼠皮层神经元氧化损伤的保护作用,并探讨其作用机制。Neurobasal(含有B-27)的培养基无血清体外原代培养新生小鼠大脑皮层神经元,H_2O_2(50μmol/L)诱导氧化应激损伤模型,MTT法检测不同浓度(0.001、0.01、0.1 g/L)G01对细胞存活的影响,生化法测定乳酸脱氢酶(LDH)释放量和丙二醛(MDA)、超氧歧化酶(SOD)的含量。与H_2O_2处理组比较,0.01、0.1 g/L G01能显著提高H_2O_2诱导损伤皮层神经元的生存率74.51%,81.31%(P<0.05),并且降低了培养液中乳酸脱氢酶(LDH)的漏出量,抑制细胞内丙二醛(MDA)的生成,提高细胞内超氧歧化酶(SOD)的活性。研究结果表明G01对H_2O_2损伤皮层神经元具有显著的保护作用其机制与抗氧化作用有关。 This study was designed to investigate the protective effects of a new chalcone derivative G01,3'-formyl-4', 6'- dihydroxy-2'-methoxy-5'-methyl-3,4-dihydroxy chalcone, on H2 02 -induced oxidative damage in cortical neurons of mice, and the underlying mechanisms. Primary cortical neurons of newborn mice were cultured in Neurobasal containing B-27, free of serum, and the oxidative damage was induced by 50 p.mol/L H2 02. After the damage, the effects of different concentrations of G01 (0.001,0.01,0o 1 g/L) on cell survival was tested by MTr assay, and the levels of LDH, MDA and SOD were measured by biochemistry assay. Compared with the damage group,0.01,0.1 g/L C01 significantly improved the survival rate of neurons to 74.51% and 81.31% ,respectively,reduced the release of LDH in the medium, inhibited MDA synthesis, and enhanced the activity of SOD. These results indicated COl had significantly protective effects against H202-induced damage in cortical neurons,and the mechanisms were related to its antioxidative effects.
机构地区 解放军第
出处 《天然产物研究与开发》 CAS CSCD 北大核心 2015年第12期2138-2141,共4页 Natural Product Research and Development
基金 国家自然科学基金(81072546 81470156)
关键词 查尔酮衍生物 小鼠神经元 氧化损伤 抗氧化 神经保护作用 chaleone analogues neurons of mice oxidative damage antioxidation neuroprotective effect
  • 相关文献

参考文献10

  • 1Ye CL, Liu Y, Wei DZ, et al. Antioxidant and anticancer ac- tivity of 3'-formyl-4,6-dihydroxy-2'- methoxy-5-methylchal- cone and ( 2S ) -8-formyl-5-ydroxyl-7-methoxy-6-methyl-fla- vanone. J Pharm Pharmacol,2007 ,59 :553-559.
  • 2梁海,向卓,马天翔,张学辉,吴久鸿.新型查尔酮化合物3'-甲酰基-4',6'-二羟基-2'-甲氧基-5'-甲基查尔酮(FMC)衍生物的合成与体外抗氧化活性研究[J].中国药学杂志,2014,49(21):1939-1944. 被引量:4
  • 3XiangZ(向卓).Study on design and synthesis of novel chal-cone Des-C ,FMC analogous and their in vitro anti-tumor,an- ti-oxidation study. Xi'an :The Fourth Military Medical Univer-8畸(解放军第四军医大学),PhD.2014.
  • 4Cucinotta FA, Wilson JW, Shinn JL, et al. Effects of target fragmentation on evaluation of LET spectra from space radia- tions:implications for space radiation protection studies. Ra- diat Meas , 1996:26:923-934.
  • 5谢荣源.阿尔茨海默病药物治疗的研究进展[J].常州大学学报(自然科学版),2014,26(3):56-63. 被引量:6
  • 6Brewer GJ. Isolation and culture of adult rat hippocampal neurons. Neurosci Methods, 1997,71 : 143-155.
  • 7Gu Y, Jing Y, Kumar A. et al. Isolation of human neuronal ceils resistant to toxicity by the prion protein peptide 106- 126. Alzheimers Dis,2001,3 : 169-180.
  • 8Li WG, Miller FJ Jr, Zhang HJ, et al. H2 O2 -induced O2" production by a non-phagocytic NAD(P) H oxidase cau- ses oxidant injury. Biol Chem,2001,3276:251-256.
  • 9Kirmula VL, Everitt JI, Whorton AR, et al. Hydrogen perox- ide production by alveolar type U cells, alveolar macropha- ges, and endothelial ceils. Am J Physiol, 1991,261 : L84-91.
  • 10Mugge A, Elwell JH, Peterson rITE, et al. Release of intact en- dothelium-derived relaxing factor depends on endothelial su- peroxide dismutase activity. Am J Physiol, 1991,260: 219- 225.

二级参考文献32

  • 1Brookmeyer R, Johnson E, Ziegler - Graham K, et al. Fore- casting the global burden of Alzheimer's disease [J]. Alzhei- meres and Dementia, 2007, 3 (3): 186 - 191.
  • 2Wenk G L. Neuropathologic changes in Alzheimer's disease [J]. J ClinPsychiatry, 2003, 64 (9): 7-10.
  • 3Ghezzi L, Scarpini E, Galimberti D. Disease - modifying drugs in Alzheimer's disease [J]. Drug Des Devel Ther, 2013, 71 1471-1478.
  • 4Galimherti D, Scarpini E. Disease - modifying treatments for Alzheimer's disease [J]. Adv Neurol Disord, 2011, 4 (4): 203 - 216.
  • 5Mahley R W, Weisgraber K H, Huang Y. Apolipoprotein E4: A causative factor and therapeutic target in neuropatholo- gy, including Alzheimer's disease [J]. Proc Natl Acad Sc USA, 2006, 103 (15): 5644-5651.
  • 6Francis P T, Palmer A M, Shape M, et al. The cholinergic hypothesis of Alzheimer's disease: a review of progress [J]. J Neurol Neurosurg Psychiatr, 1999, 56 (2): 137 - 147.
  • 7Hardy J, Allsop D. Amyloid deposition as the central event in the aetiology of Alzheimers disease [J]. Trends Pharmacol Sci, 1991, 12 (10): 383-388.
  • 8Nikolaev A, McLaughlin T, O'Leary D, et al. APP binds DR6 to cause axon pruning and neuron death via distinct caspas- es [J]. Nature, 2009, 457: 981- 989.
  • 9Hern6ndez F, Avi|a J. Tauopathies [J]. Cel| Moi Life Sci, 2007, 64 (17): 2219-2233.
  • 10Mudher A, Lovestone S. Alzheimers disease - do tauists and baptists finally shake hands? [J]. Trends Neurosci, 2002, 25 (1): 22-26.

共引文献8

同被引文献27

引证文献5

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部